INOVIO Reports Fourth Quarter 2021 and Year-End Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. STZ
4. PENG
5. NVDA
6. SPY
7. MSFT
8. SKYD
9. LEVI
10. APLD

Go back to INOVIO Reports Fourth Quarter 2021 and Year-End Financial Results

Inovio Pharmaceuticals (INO) PT Lowered to $30 at Oppenheimer

March 2, 2022 12:56 PM EST

Oppenheimer analyst Hartaj Singh lowered the price target on Inovio Pharmaceuticals (NASDAQ: INO) to $30.00 (from $35.00) while maintaining an Outperform rating after the company provided a business and pipeline update to investors on 3/1.

The analyst commented, "While the company reported steady progress, the... More

Inovio Pharma (INO) Misses Q4 EPS by $1.13

March 1, 2022 4:33 PM EST

Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($1.45), $1.13 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $2.84 million.

For earnings history and earnings-related data on Inovio Pharma (INO) click here.

... More